TNF and inflammatory bowel disease: In studies where accuracy data on SpA were available (35–48), we identified a total of 27 combinations for IBD associated SpA, mostly involving VED with anti-TNF or JAKi, and less frequent combinations of UTK with anti-TNF, VED, or JAKi.